Rising Prevalence of Viral Diseases Drives Growth in Biomanufacturing Viral Detection and Quantification Market

The Biomanufacturing Viral Detection Quantification market is expected to grow from an estimated USD 491.5 million in 2024 to USD 999.0 million in 2033 at a CAGR of 8.20%. The increasing spread of viral diseases is a key factor propelling the growth of the global biomanufacturing viral detection and quantification market. According to the World Health Organization (WHO), nearly half of the global population is at risk of contracting dengue, with annual infections estimated between 100 and 400 million. Dengue, a mosquito-borne virus, is particularly widespread in tropical and subtropical regions, with most cases occurring in urban and semi-urban areas. The number of reported dengue cases has surged over the past two decades, from approximately 505,430 cases in 2000 to 5.2 million in 2019, underscoring the need for early detection and swift medical intervention.

Biomanufacturing viral detection and quantification tools, such as diagnostic kits and assays, allow healthcare providers to identify viruses accurately and quickly in patient samples. Early detection facilitates timely treatment and containment, helping to curb the spread of infections and improve patient outcomes. These tools also play a crucial role in epidemiological monitoring, enabling health authorities to track outbreaks, identify disease patterns, and assess the effectiveness of control measures. The global response to health emergencies, such as the COVID-19 pandemic, has highlighted the importance of reliable viral detection technologies. Governments, healthcare systems, and businesses are increasingly investing in biomanufacturing infrastructure to enhance preparedness for future outbreaks, driving demand for scalable viral detection solutions.

Get Free Sample Report and Related Graphs & Charts @https://www.emergenresearch.com/request-sample/3612

Market Drivers: Stricter Regulations on Viral Safety

The market for biomanufacturing viral detection and quantification is also being driven by stricter regulatory requirements for viral safety. Viral clearance studies are a crucial step in biologics production, ensuring product safety before regulatory approval. Regulatory agencies emphasize the need for rigorous testing and data validation to support applications for investigational new drugs (INDs) and biologics license applications (BLAs). Over the past few decades, guidelines have been established to reduce the risk of viral transmission in pharmaceutical products. In 2022, the International Council for Harmonisation (ICH) introduced new guidelines for testing and evaluating the viral safety of biotechnology products derived from human or animal cell lines. These guidelines provide biopharmaceutical manufacturers with detailed information on required tests and safety data for marketing applications, ensuring stringent virus clearance measures are in place.

Market Challenges: High Research and Development Costs

Despite strong market growth, high research and development (R&D) costs present a significant challenge. Developing and validating new viral detection methods involves extensive investment, which can strain the financial resources of smaller companies and startups. Limited funding may hinder innovation and restrict competition, slowing the introduction of new and advanced detection technologies. Additionally, lengthy and costly R&D processes can delay the availability of critical viral detection solutions during outbreaks. Ensuring accuracy and reliability in complex sample matrices and rapidly evolving viruses further adds to these costs. The production of high-quality reagents and materials for viral detection requires significant investment in research, manufacturing, and quality control, posing additional financial barriers for market players.

Market Segmentation: Consumables Leading, Instruments Growing Rapidly

The biomanufacturing viral detection and quantification market is segmented into consumables, instruments, and services. In 2023, consumables emerged as the leading segment, driven by the widespread use of testing kits, reagents, and accessories essential for viral detection procedures. Consumables are used repeatedly throughout the testing process, ensuring efficient and accurate viral analysis.

The instruments segment is experiencing the fastest growth, fueled by the rising demand for advanced viral detection technologies. High-performance tools such as Polymerase Chain Reaction (PCR) devices, next-generation sequencing systems, and other high-throughput technologies are becoming increasingly important for ensuring product safety and regulatory compliance in biomanufacturing. The need for rapid and precise results is driving investments in cutting-edge diagnostic instruments, further accelerating market expansion.

As viral diseases continue to pose significant public health challenges, the demand for effective detection and quantification tools is set to rise. The biomanufacturing sector is expected to witness continued investment in research and technology to enhance diagnostic capabilities, improve outbreak preparedness, and ensure compliance with stringent safety regulations. Industry stakeholders, including healthcare providers, governments, and biotech companies, are actively working to develop innovative solutions that can respond swiftly to emerging viral threats and safeguard global health.

Request A Discount On The Report @https://www.emergenresearch.com/request-discount/3612

Biomanufacturing Viral Detection Quantification Top Companies and Competitive Landscape

The Biomanufacturing Viral Detection Quantification Industry is essential for the safety and efficacy of biopharmaceutical products. This industry develops methods and technologies to detect and quantify viral contaminants in biological materials. Demand for biologics and advanced therapies has been on the increase, making the need for reliable viral detection critical.

The key players in the market are Danaher Corporation, Merck KGaA, New England Biolabs, and TAKARA HOLDINGS INC., which have been accredited for their innovative solutions and the quality assurance measures they use. As regulatory demands increase the industry is also expected to grow with the developments in the detection technologies and increased attention towards ensuring safety in bioprocessing.

In September 2021, Thermo Fisher Scientific signed a definitive agreement with Becton, Dickinson, and Company (BDX) to acquire their Advanced Bioprocessing division. This BD company generated over $100 million in annual revenue and was acquired by Thermo Fisher's Life Sciences Solutions Segment on October 16, 2021.

Some of the key companies in the global Biomanufacturing Viral Detection Quantification market include:

Danaher Corporation

Merck KGaA

New England Biolabs

TAKARA HOLDINGS INC.

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

Sartorius AG

Charles River Laboratories

Bio-Rad Laboratories, Inc.

PerkinElmer, Inc.

Promega Corporation

QIAGEN N.V.

Genscript Biotech Corporation

Norgen Biotek Corp.

Request Customization Of The Report @https://www.emergenresearch.com/request-for-customization/3612

Biomanufacturing Viral Detection Quantification Latest Industry Updates

In March 2023, Danaher Corporation, a global leader in research and technology, and the University of Pennsylvania (Penn) collaborated to explore new cell therapy approaches. The multiyear partnership's goals are to develop new technologies, decrease production bottlenecks, and give patients next-generation engineered cell products with more consistent clinical results.

In June 2023. Merck, one of the world's premier scientific and technology corporations, is expanding manufacturing capacity for highly purified reagents at its Nantong facility, which is a significant transportation hub in China and serves the Yangtze River Delta region. The €70 million investment will allow for the large-scale manufacturing of high-purity reagents for quality control and testing to fulfil the needs of biopharma clients, with an annual output increase of several thousand tonnes. Today. Merck struck an agreement to assist the expansion of the Nantong plant with the Nantong economic and technology development area (NETDA).

Biomanufacturing Viral Detection Quantification Market Segmentation Analysis

Offering Type Outlook (Revenue, USD Million; 2020-2033)

Consumables

Instruments

Services

Technology Outlook (Revenue, USD Million; 2020-2033)

PCR

ELISA

Flow Cytometry

Plaque Assay

Others

Application Outlook (Revenue, USD Million; 2020-2033)

Blood and Blood Products Manufacturing

Vaccines and Therapeutics Manufacturing

Cellular and Gene Therapy Products Manu

Stem Cell Products Manufacturing

Tissue and Tissue Products Manufacturing

End User Outlook (Revenue, USD Million; 2020-2033)

Life Science Companies

Testing Laboratories

CROs and CDMOs

Regional Outlook (Revenue, USD Million; 2020-2033)

North America

United States

Canada

Mexico

Europe

Germany

France

United Kingdom

Italy

Spain

Benelux

Rest of Europe

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Latin America

Brazil

Rest of Latin America

Middle East and Africa

Saudi Arabia

UAE

South Africa

Turkey

Rest of MEA

Click here to Buy Now @https://www.emergenresearch.com/select-license/3612

Read Similar Reports By Emergen Research:

Biomanufacturing Viral Detection Quantification Market Size @ https://www.emergenresearch.com/industry-report/biomanufacturing-viral-detection-quantification-market/market-size

 Biomanufacturing Viral Detection Quantification Market Share @ https://www.emergenresearch.com/industry-report/biomanufacturing-viral-detection-quantification-market/market-share

 Biomanufacturing Viral Detection Quantification Market Trends @ https://www.emergenresearch.com/industry-report/biomanufacturing-viral-detection-quantification-market/market-trends

 Biomanufacturing Viral Detection Quantification Regional Market Demand @ https://www.emergenresearch.com/industry-report/biomanufacturing-viral-detection-quantification-market/regional-market-demand

 Biomanufacturing Viral Detection Quantification Market Analysis @ https://www.emergenresearch.com/industry-report/biomanufacturing-viral-detection-quantification-market/market-analysis

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.